Crucial Role of microRNAs as New Targets for Amelogenesis Disorders Detection

被引:0
作者
Masunova, Nadezhda [1 ]
Tereschenko, Maria [1 ]
Alexandrov, Georgy [1 ]
Spirina, Liudmila [1 ,2 ]
Tarasenko, Natalia [1 ,3 ]
机构
[1] Siberian State Med Univ, Minist Hlth Russia, Tomsk 634050, Russia
[2] Russian Acad Sci, Canc Res Inst, Tomsk Natl Res Med Ctr, Tomsk, Russia
[3] Russian Acad Sci, Res Inst Med Genet, Tomsk Natl Res Med Ctr, Tomsk, Russia
关键词
Amelogenesis imperfecta; genetic factors; growth factors; calcium metabolism; microRNA; liquid biopsy; GENE-PRODUCTS; GROWTH-FACTOR; IMPERFECTA; MINERALIZATION; AMELOBLASTIN; EXPRESSION; CHANNELS;
D O I
10.2174/0113894501257011231030161427
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction Amelogenesis imperfecta (AI) refers to a heterogeneous group of conditions with multiple factors which contribute to the hypomineralisation of enamel. Preventive measures are necessary to predict this pathology. Prospects for preventive medicine are closely related to the search for new informative methods for diagnosing a human disease. MicroRNAs are prominent for the non-invasive diagnostic platform.The Aim of the Study The aim of the review is to review the heterogeneous factors involved in amelogenesis and to select the microRNA panel associated with the AI type.Methods We used DIANA Tools (algorithms, databases and software) for interpreting and archiving data in a systematic framework ranging from the analysis of expression regulation from deep sequencing data to the annotation of miRNA regulatory elements and targets (https://dianalab.e-ce.uth.gr/). In our study, based on a gene panel associated with the AI types, twenty-four miRNAs were identified for the hypoplastic type (supplement), thirty-five for hypocalcified and forty-nine for hypomaturation AI. The selection strategy included the microRNA search with multiple targets using the AI type's gene panel.Results Key proteins, calcium-dependent and genetic factors were analysed to reveal their role in amelogenesis. The role of extracellular non-coding RNA sequences with multiple regulatory functions seems to be the most attractive. We chose the list of microRNAs associated with the AI genes. We found four microRNAs (hsa-miR-27a-3p, hsa-miR-375, hsa-miR-16-5p and hsa-miR-146a-5p) for the gene panel, associated with the hypoplastic type of AI; five microRNAs (hsa-miR-29c-3p, hsa-miR-124-3p, hsa-miR-1343-3p, hsa-miR-335-5p, and hsa-miR-16-5p - for hypocalcified type of AI, and seven ones (hsa-miR-124-3p, hsa-miR-147a, hsa-miR-16-5p, hsa-miR-429, hsa-let-7b-5p, hsa-miR-146a-5p, hsa-miR-335-5p) - for hypomaturation. It was revealed that hsa-miR-16-5p is included in three panels specific for both hypoplastic, hypocalcified, and hypomaturation types. Hsa-miR-146a-5p is associated with hypoplastic and hypomaturation type of AI, which is associated with the peculiarities of the inflammatory response immune response. In turn, hsa-miR-335-5p associated with hypocalcified and hypomaturation type of AI.Conclusion Liquid biopsy approaches are a promising way to reduce the economic cost of treatment for these patients in modern healthcare. Unique data exist about the role of microRNA in regulating amelogenesis. The list of microRNAs that are associated with AI genes and classified by AI types has been uncovered. The target gene analysis showed the variety of functions of selected microRNAs, which explains the multiple heterogeneous mechanisms in amelogenesis. Predisposition to mineralisation problems is a programmed event. Many factors determine the manifestation of this problem. Additionally, it is necessary to remember the variable nature of the changes, which reduces the prediction accuracy. Therefore, models based on liquid biopsy and microRNAs make it possible to take into account these factors and their influence on the mineralisation. The found data needs further investigation.Conclusion Liquid biopsy approaches are a promising way to reduce the economic cost of treatment for these patients in modern healthcare. Unique data exist about the role of microRNA in regulating amelogenesis. The list of microRNAs that are associated with AI genes and classified by AI types has been uncovered. The target gene analysis showed the variety of functions of selected microRNAs, which explains the multiple heterogeneous mechanisms in amelogenesis. Predisposition to mineralisation problems is a programmed event. Many factors determine the manifestation of this problem. Additionally, it is necessary to remember the variable nature of the changes, which reduces the prediction accuracy. Therefore, models based on liquid biopsy and microRNAs make it possible to take into account these factors and their influence on the mineralisation. The found data needs further investigation.
引用
收藏
页码:1139 / 1149
页数:11
相关论文
共 50 条
  • [21] The role of MicroRNAs in the diagnosis and treatment of oral premalignant disorders
    Fathima, J. H. Shazia
    Jayaraman, Selvaraj
    Sekar, Ramya
    Syed, Nazmul Huda
    ODONTOLOGY, 2024, 112 (04) : 1023 - 1032
  • [22] The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies
    Corsini, Lidia Rita
    Bronte, Giuseppe
    Terrasi, Marianna
    Amodeo, Valeria
    Fanale, Daniele
    Fiorentino, Eugenio
    Cicero, Giuseppe
    Bazan, Viviana
    Russo, Antonio
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 : S103 - S109
  • [23] MicroRNAs: new biomarkers and therapeutic targets after cardiac arrest?
    Devaux, Yvan
    Stammet, Pascal
    Friberg, Hans
    Hassager, Christian
    Kuiper, Michael A.
    Wise, Matt P.
    Nielsen, Niklas
    CRITICAL CARE, 2015, 19
  • [24] MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?
    Nadim, Wissem Deraredj
    Simion, Viorel
    Benedetti, Helene
    Pichon, Chantal
    Baril, Patrick
    Morisset-Lopez, Severine
    CURRENT NEUROPHARMACOLOGY, 2017, 15 (02) : 260 - 275
  • [25] Epigenetic Mechanisms in CRSwNP: The Role of MicroRNAs as Potential Biomarkers and Therapeutic Targets
    Gatsounia, Alkmini
    Schinas, Georgios
    Danielides, Gerasimos
    Grafanaki, Katerina
    Mastronikolis, Nicholas
    Stathopoulos, Constantinos
    Lygeros, Spyridon
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2025, 47 (02)
  • [26] Regulation of Large Number of Weak Targets-New Insights from Twin-microRNAs
    Zhao, Yixin
    Lin, Pei
    Liufu, Zhongqi
    Yang, Hao
    Lyu, Yang
    Shen, Xu
    Wu, Chung-I
    Tang, Tian
    GENOME BIOLOGY AND EVOLUTION, 2018, 10 (05): : 1255 - 1264
  • [27] Biogenesis of microRNAs and their role in the development and course of selected hematologic disorders
    Grenda, Anna
    Budzynski, Michal
    Filip, Agata A.
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2013, 67 : 174 - 185
  • [28] Intestinal Fibrosis in Crohn's Disease: Role of microRNAs as Fibrogenic Modulators, Serum Biomarkers, and Therapeutic Targets
    Lewis, Amy
    Nijhuis, Anke
    Mehta, Shameer
    Kumagai, Tomoko
    Feakins, Roger
    Lindsay, James O.
    Silver, Andrew
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (05) : 1141 - 1150
  • [29] The role of microRNAs in oral lichenoid disorders. Systematic review
    Setien-Olarra, Amaia
    Gainza-Cirauqui, Maria-Luisa
    Manuel Aguirre-Urizar, Jose
    Marichalar-Mendia, Xabier
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2017, 22 (05): : E548 - E553
  • [30] MicroRNAs in Obesity-Associated Disorders: The Role of Exercise Training
    Silveira, Andre
    Gomes, Joao
    Roque, Fernanda
    Fernandes, Tiago
    de Oliveira, Edilamar Menezes
    OBESITY FACTS, 2022, 15 (02) : 105 - 117